Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share
November 19, 2014 3:29 PM ESTNorthwest Biotherapeutics (NASDAQ: NWBO) reported Q3 EPS of ($0.35), versus ($0.65) reported last year. Revenue for the quarter came in at $582 thousand, versus $400 thousand reported last year.
For earnings history and earnings-related data on Northwest Biotherapeutics (NWBO) click here.
... More


